Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (3) Blüthgen, Nils (2) Burkert, Christian Martin (1) Conrad, Thomas Dr. (1) Dörr, Jan Rafael (1) Forbes, Martin Dr. (1) Henssen, Anton Prof. Dr. med. (12) Kempa, Stefan Dr. (2) Kirchner, Marieluise Dr. (1) Mastrobuoni, Guido Dr. (2) Mertins, Philipp Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Röefzaad, Claudia (2) Schwarz, Roland Dr. (2) Wolf, Jana Prof. Dr. (1) 2004 (2) 2006 (1) 2008 (6) 2009 (5) 2010 (4) 2011 (3) 2012 (4) 2013 (5) 2014 (1) 2015 (2) 2016 (2) 2017 (6) 2018 (1) 2019 (1) 2020 (10) 2021 (9) 2022 (11) 2023 (5) 2024 (1) Advanced Light Microscopy (43) AG Müller/Dechend (ECRC) (470) AG Schreiber [ECRC] (57) Allosteric Proteomics Lab (18) Anchored Signalling (114) Angiogenesis & Metabolism Laboratory (58) Animal Phenotyping (50) Biobank (418) Bioinformatics and Omics Data Science (89) Bioinformatics of RNA Structure and Transcriptome Regulation (47) Biology of Malignant Lymphomas (97) Biomedical Image Analysis (52) Cancer Genetics and Cellular Stress Responses (95) Cardiac MRI (279) Cardiovascular-Hematopoietic Interaction (15) Cell Biology of Immunity (52) Cellular Neurosciences (454) Chromatin (dys)function in disease (19) Clinical Research Unit (21) Clinic of Psychiatry / Modul Psychiatry of Aging (68) Computational methodologies and omic analytics (13) Computational Regulatory Genomics (165) Cryo-Electron Microscopy (17) Developmental Biology / Signal Transduction (211) Developmental Neurobiology (110) Development and Function of Neural Circuits (34) Electron Microscopy (7) Endocrinology, Diabetes and Nutritional Medicine (36) (-) Epigenetic Modifications in Neuroblastoma (79) Epigenetic Regulation and Chromatin Architecture (128) Experimental Ultrahigh-Field MR (337) Flow Cytometry (8) From Cell States to Function (7) Gastrointestinal Barrier, Regeneration and Carcinogenesis (44) Genetics and Genomics of Cardiovascular Diseases (429) Genetics of Congenital Heart Disease (68) Genetics of Metabolic and Reproductive Disorders (24) Genome Diversification & Integrity (29) Genome Engineering & Disease Models (155) Genome instability and somatic mosaicism (40) Genomics (324) Host-microbiome factors in cardiovascular disease (134) Hypertension-caused End-Organ Damage (470) Hypertension-Mediated End-Organ Damage (470) Image Data Analysis (16) immune Cell Function in Health and Disease (29) Immune Dysregulations in Oncology (68) Immune Mechanisms and Human Antibodies (22) Immune Regulation and Cancer (95) Innate Immunity & Neuroinflammation (66) In Situ Structural Biology (55) Integrative Vascular Biology (162) Interdisciplinary Retina Research (109) Intracellular Proteolysis (137) Kidney Cell Engineering (17) Magnetic Resonance (337) Mathematical Cell Physiology (125) Mathematical Modelling of Cellular Processes (60) Mechanism-based Cancer Therapies (84) Microenvironmental Regulation in Autoimmunity and Cancer (84) Mobile DNA (188) Molecular and cellular basis of behavio (9) Molecular Biology of Peptide Hormones (783) Molecular Cardiovascular Research (204) Molecular Epidemiology (418) Molecular Genetics of Chronic Inflammation and Allergic Disease (89) Molecular Immunology and Gene Therapy (239) Molecular mechanisms of environment sensing (12) Molecular Oncology (25) Molecular Pathways in Cortical Development (30) Molecular Physiology of Somatic Sensation (174) Myology (135) Nephrology and Inflammatory Vascular Diseases (159) Neural Circuits and Behaviour (60) Neuroimmunology Laboratory (51) Neurovascular link in neuroendocrine tumors (8) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (28) Organoids (9) Out-patient Clinic for Neuroimmunology (673) Out-patient Clinic for Pediatric Allergology and Atopic Dermatitis (89) Pancreatic Organoid Research and Disease Modeling (129) Pathogenesis of ANCAinduced Glomerulonephritis (109) Pluripotent Stem Cells (71) Protein Production and Characterization (27) Proteome Dynamics (137) Proteomics (131) Proteomics and Metabolomics (99) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (375) Psychoneuroimmunology (46) Quantitative Developmental Biology (50) Quantitative Stem Cell Biology (28) RNA Biology and Posttranscriptional Regulation (138) Single Molecule Biophysics probing Quantitative Neuroscience (14) Spatial Proteomics (26) Stem Cell Dynamics and Mitochondrial Genomics (42) Stem Cell Modeling of Development and Disease (20) Structural Biology of Membrane-Associated Processes (109) Synaptic Transmission and Plasticity (209) Systems Biology Imaging (35) Systems biology of cardiovascular and neuronal pathologies (11) Systems Biology of Gene Regulatory Elements (187) Systems Hematology, Stem Cells & Precision Medicine (45) Transgenics (155) Translational Approaches in Heart Failure and Cardiometabolic Disease (118) Translational Bioinformatics (100) Translational Cardiology and Functional Genomics (102) Translational Neuroimmunology (55) Translational Oncology of Solid Tumors (915) Translational Organ Models (68) Translational Tumorimmunology (33) Tumor heterogeneity and treatment resistance in pediatric cancer (8) 79 Results: Active Filter: Epigenetic Modifications in Neuroblastoma Sort: Result score Newest to oldest Oldest to newest July 01, 2016 / J Proteome Res Minichromosome maintenance complex is a critical node in the miR-183 signaling network of MYCN-amplified neuroblastoma cells M. Lodrini G. Poschmann V. Schmidt J. Wünschel D. Dreidax O. Witt T. Höfer H.E. Meyer K. Stühler A. Eggert H.E. Deubzer January 01, 2018 / Oncotarget Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma V. Arnhold K. Schmelz J. Proba A. Winkler J. Wünschel J. Toedling H.E. Deubzer A. Künkele A. Eggert J.H. Schulte P. Hundsdoerfer April 01, 2017 / Am J Med Genet A Childhood cancer predisposition syndromes - a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology T. Ripperger S.S. Bielack A. Borkhardt I.B. Brecht B. Burkhardt G. Calaminus K.M. Debatin H. Deubzer U. Dirksen C. Eckert A. Eggert M. Erlacher G. Fleischhack M.C. Frühwald A. Gnekow G. Goehring N. Graf H. Hanenberg J. Hauer B. Hero S. Hettmer K. von Hoff M. Horstmann J. Hoyer T. Illig P. Kaatsch R. Kappler K. Kerl T. Klingebiel U. Kontny U. Kordes D. Körholz E. Koscielniak C.M. Kramm M. Kuhlen A.E. Kulozik B. Lamottke I. Leuschner D.R. Lohmann A. Meinhardt M. Metzler L.H. Meyer O. Moser M. Nathrath C.M. Niemeyer R. Nustede K.W. Pajtler C. Paret M. Rasche D. Reinhardt O. Rieß A. Russo S. Rutkowski B. Schlegelberger D. Schneider R. Schneppenheim M. Schrappe C. Schroeder D. von Schweinitz T. Simon M. Sparber-Sauer C. Spix M. Stanulla D. Steinemann B. Strahm P. Temming K. Thomay A.O. von Bueren P. Vorwerk O. Witt M. Wlodarski W. Wössmann M. Zenker S. Zimmermann S.M. Pfister C.P. Kratz January 24, 2017 / Oncotarget The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models K.W. Pajtler N. Sadowski S. Ackermann K. Althoff K. Schönbeck K. Batzke S. Schäfers A. Odersky L. Heukamp K. Astrahantseff A. Künkele H.E. Deubzer A. Schramm A. Sprüssel T. Thor S. Lindner A. Eggert M. Fischer J.H. Schulte August 01, 2020 / Gynäkologe Melanozytäre Naevi der Haut bei einem Neugeborenen [Dermal melanocytic nevi in a newborn] S. Endres M. Wilke A. Höche A. Gertz R. Schubert H. Deubzer A. Eggert R. Rossi D. Schlembach September 01, 2020 / Eur J Cancer Accelerating drug development for neuroblastoma: summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma L. Moreno G. Barone S.G. DuBois J. Molenaar M. Fischer J. Schulte A. Eggert G. Schleiermacher F. Speleman L. Chesler B. Geoerger M.D. Hogarty M.S. Irwin N. Bird G.B. Blanchard S. Buckland H. Caron S. Davis B. De Wilde H.E. Deubzer E. Dolman M. Eilers R.E. George S. George Š. Jaroslav J.M. Maris L. Marshall M. Merchant P. Mortimer C. Owens A. Philpott E. Poon J.W. Shay R. Tonelli D. Valteau-Couanet G. Vassal J.R. Park A.D.J. Pearson November 01, 2020 / J Mol Diagn Multiplexed quantification of four neuroblastoma DNA targets in a single droplet digital PCR reaction. C. Peitz A. Sprüssel R.B. Linke K. Astrahantseff M. Grimaldi K. Schmelz J. Toedling J.H. Schulte M. Fischer C. Messerschmidt D. Beule U. Keilholz A. Eggert H.E. Deubzer M. Lodrini June 01, 2021 / Children Germline mutations including the rare pathogenic variant c.3206delC in the ATM gene cause ataxia teleangiectasia-associated primary central nervous system lymphoma J.R. Dörr A. Thorwarth A. Mizia-Malarz J. Radke A. Tietze P. Hernáiz-Driever D. Horn A. Gratopp A. Eggert H.E. Deubzer June 30, 2021 / J Enzyme Inhib Med Chem Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect B. Arlt G. Mastrobuoni J. Wuenschel K. Astrahantseff A. Eggert S. Kempa H.E. Deubzer November 01, 2020 / Children Sinusoidal obstruction syndrome following myeloablative therapy and tranexamic acid treatment for hemorrhage in two patients with neuroblastoma F. Zirngibl C. Flemmig P. Lang A. Künkele A. Eggert J.H. Schulte H.E. Deubzer Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next › Last page Last »
July 01, 2016 / J Proteome Res Minichromosome maintenance complex is a critical node in the miR-183 signaling network of MYCN-amplified neuroblastoma cells M. Lodrini G. Poschmann V. Schmidt J. Wünschel D. Dreidax O. Witt T. Höfer H.E. Meyer K. Stühler A. Eggert H.E. Deubzer
January 01, 2018 / Oncotarget Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma V. Arnhold K. Schmelz J. Proba A. Winkler J. Wünschel J. Toedling H.E. Deubzer A. Künkele A. Eggert J.H. Schulte P. Hundsdoerfer
April 01, 2017 / Am J Med Genet A Childhood cancer predisposition syndromes - a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology T. Ripperger S.S. Bielack A. Borkhardt I.B. Brecht B. Burkhardt G. Calaminus K.M. Debatin H. Deubzer U. Dirksen C. Eckert A. Eggert M. Erlacher G. Fleischhack M.C. Frühwald A. Gnekow G. Goehring N. Graf H. Hanenberg J. Hauer B. Hero S. Hettmer K. von Hoff M. Horstmann J. Hoyer T. Illig P. Kaatsch R. Kappler K. Kerl T. Klingebiel U. Kontny U. Kordes D. Körholz E. Koscielniak C.M. Kramm M. Kuhlen A.E. Kulozik B. Lamottke I. Leuschner D.R. Lohmann A. Meinhardt M. Metzler L.H. Meyer O. Moser M. Nathrath C.M. Niemeyer R. Nustede K.W. Pajtler C. Paret M. Rasche D. Reinhardt O. Rieß A. Russo S. Rutkowski B. Schlegelberger D. Schneider R. Schneppenheim M. Schrappe C. Schroeder D. von Schweinitz T. Simon M. Sparber-Sauer C. Spix M. Stanulla D. Steinemann B. Strahm P. Temming K. Thomay A.O. von Bueren P. Vorwerk O. Witt M. Wlodarski W. Wössmann M. Zenker S. Zimmermann S.M. Pfister C.P. Kratz
January 24, 2017 / Oncotarget The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models K.W. Pajtler N. Sadowski S. Ackermann K. Althoff K. Schönbeck K. Batzke S. Schäfers A. Odersky L. Heukamp K. Astrahantseff A. Künkele H.E. Deubzer A. Schramm A. Sprüssel T. Thor S. Lindner A. Eggert M. Fischer J.H. Schulte
August 01, 2020 / Gynäkologe Melanozytäre Naevi der Haut bei einem Neugeborenen [Dermal melanocytic nevi in a newborn] S. Endres M. Wilke A. Höche A. Gertz R. Schubert H. Deubzer A. Eggert R. Rossi D. Schlembach
September 01, 2020 / Eur J Cancer Accelerating drug development for neuroblastoma: summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma L. Moreno G. Barone S.G. DuBois J. Molenaar M. Fischer J. Schulte A. Eggert G. Schleiermacher F. Speleman L. Chesler B. Geoerger M.D. Hogarty M.S. Irwin N. Bird G.B. Blanchard S. Buckland H. Caron S. Davis B. De Wilde H.E. Deubzer E. Dolman M. Eilers R.E. George S. George Š. Jaroslav J.M. Maris L. Marshall M. Merchant P. Mortimer C. Owens A. Philpott E. Poon J.W. Shay R. Tonelli D. Valteau-Couanet G. Vassal J.R. Park A.D.J. Pearson
November 01, 2020 / J Mol Diagn Multiplexed quantification of four neuroblastoma DNA targets in a single droplet digital PCR reaction. C. Peitz A. Sprüssel R.B. Linke K. Astrahantseff M. Grimaldi K. Schmelz J. Toedling J.H. Schulte M. Fischer C. Messerschmidt D. Beule U. Keilholz A. Eggert H.E. Deubzer M. Lodrini
June 01, 2021 / Children Germline mutations including the rare pathogenic variant c.3206delC in the ATM gene cause ataxia teleangiectasia-associated primary central nervous system lymphoma J.R. Dörr A. Thorwarth A. Mizia-Malarz J. Radke A. Tietze P. Hernáiz-Driever D. Horn A. Gratopp A. Eggert H.E. Deubzer
June 30, 2021 / J Enzyme Inhib Med Chem Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect B. Arlt G. Mastrobuoni J. Wuenschel K. Astrahantseff A. Eggert S. Kempa H.E. Deubzer
November 01, 2020 / Children Sinusoidal obstruction syndrome following myeloablative therapy and tranexamic acid treatment for hemorrhage in two patients with neuroblastoma F. Zirngibl C. Flemmig P. Lang A. Künkele A. Eggert J.H. Schulte H.E. Deubzer